<DOC>
	<DOCNO>NCT02548572</DOCNO>
	<brief_summary>Several study show TES RP patient may help slow progressive deterioration degenerative disease . The end point clinical trial slow stop disease progression weekly treatment use TES 1 year .</brief_summary>
	<brief_title>Transcorneal Electrical Stimulation Treatment Retinitis Pigmentosa - Safety Efficacy Multicenter Study</brief_title>
	<detailed_description>The follow propose study ( ICM1TES/RP ) investigate therapeutic aspect transcorneal electrical stimulation ( TES ) eye patient retinitis pigmentosa ( RP ) . It utilize Okuvision TES system , Wills Eye Hospital-sponsored FDA non-significant risk ( NSR ) medical device , OkuStim® ( CE-marked OkuStim® ) application electrical stimulation directly eye via corneal contact electrode . Study Design - Multi-center , prospective , randomized sham control 1:1 Clinical trial . Study treatment - Patients randomize 1:1 ratio . Patients treatment group TES 200 % phosphene threshold 30 minute weekly 52 week eyes . Patients sham group also wear electrode eye , energy turn eye sham . Duration study - anticipate duration 36 month , 12 month recruitment , 12 month treatment sham group follow 18 month , plus 6 month analysis . Inclusion Criteria - Diagnosis RP , 22-80 year age , ocular disease , able complete visit . Treatments - TES , 30 minute treatment weekly 52 week 0.8mA Number patient - 90 patient treatment arm 90 patient sham arm . Electrodes place eye , eye treat treatment group sham group eye consider . However due possibility drop use 15 % recruit 210 patient ( 15 patient per center ) . Screening - 1 . VA &amp; Phosphene threshold evaluation 2 . Vfiii4e , vfVe , Octopus 900 , complete eye exam , fundus photo , OCT Contrast sensitivity , electro-physiology . 3 . Eligibility requirement meet , schedule baseline . Tests - Base Line : VA , vfiii4e , vfVe , Octopus 900 , complete eye exam , fundus photo , OCT , Contrast sensitivity , NEI VFQ-25 , Photopic B-wave ERG , blood draw genetic test ( unless genetic profile do ) . 3 Month visit : VA , eye exam , Phosphene threshold , OCT &amp; Photopic B-wave . 6 Month visit : VA , vfiii4e , vfVe , Octopus 900 , complete eye exam , OCT &amp; Contrast sensitivity , phosphine threshold &amp; Photopic B-wave . 9 Month visit : VA , eye exam , Phosphene threshold , OCT &amp; Photopic B-wave . 12 Month visit : VA , vfiii4e , vfVe , Octopus 900 , complete eye exam , OCT &amp; Contrast sensitivity , NEI VFQ-25 , phosphene threshold &amp; Photopic B-wave 18 Month visit : VA , vfiii4e , vfVe , Octopus 900 , complete eye exam , OCT &amp; Contrast sensitivity , NEI VFQ-25 &amp; phosphene threshold &amp; Photopic B-wave .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>1 . Patients Retinitis Pigmentosa . 2 . Adult patient , 2280 year age , provide write informed consent HIPAA authorization . 3 . LogMAR VA 1.00 good eye . 4 . Octopus 900 Central Visual Field ≥10 degrees diameter around central fixation use stimulus size III4e V4e eye kinetic testing . 5 . Agree discontinue Vitamin A use intake least 2 month prior baseline visit . 1 . Visual field loss demonstrate Octopus 900 kinetic perimetry &lt; 10 deg remain central visual field use stimulus size III4e V4e . 2 . Due distance reason , patient unable travel Philadelphia respective center treatment procedure followup examination . 3 . Diabetic retinopathy 4 . Ocular neovascularisation origin 5 . After arterial venous occlusion 6 . After retinal detachment vitreoretinal surgery without implantation . 7 . Silicone oil tamponade 8 . Dry exudative agerelated macular degeneration 9 . Macular edema involve foveal center determine SDOCT 10 . All form glaucoma 11 . Any form corneal degeneration reduce visual acuity 12 . Systemic disease difficult control manage , could hinder regular attendance followup examination 13 . Patients permanently poor general condition , could hinder regular attendance followup examination 14 . Patients phosphenes inducible great , include , 0.8 mA . 15 . Forms mental illness relate bipolar affective schizoidaffective disorder , epilepsy , form dementia 16 . Simultaneous participation another interventional study history intervention whose effect may still persist 17 . Current pregnancy , woman childbearing potential unwilling use medically acceptable mean birth control study duration , woman unwilling perform pregnancy test study entry 18 . Any patient exclude study determine Principal Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Transcorneal Electrical Stimulation</keyword>
	<keyword>TES</keyword>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>RP</keyword>
</DOC>